Leukemia Research
Volume 27, Issue 9 , Pages 765-774 , September 2003

The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype

  • Clive S Zent

      Affiliations

    • Division of Hematology/Oncology, Central Arkansas Healthcare System and University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA
    • Department of Pathology and Laboratory Medicine Service, Central Arkansas Healthcare System and University of Arkansas for Medical Sciences, 113/LR, 43001 W. 7th Street, Little Rock, AR 72205–5484, USA
    • Corresponding Author InformationCorresponding author. Address from 1st April 2003: Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1-507-284-2511; fax: +1-507-266-4972.
    • ,
  • Fenghuang Zhan

      Affiliations

    • Donna and Donald Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA
    • Tel.: +1-501-296-1503x1410; fax: +1-501-686-6442.
    • ,
  • Steven A Schichman

      Affiliations

    • Department of Pathology and Laboratory Medicine Service, Central Arkansas Healthcare System and University of Arkansas for Medical Sciences, 113/LR, 43001 W. 7th Street, Little Rock, AR 72205–5484, USA
    • Tel.: +1-501-257-6445; fax: +1-501-257-6441.
    • ,
  • Klaus H.W Bumm

      Affiliations

    • Donna and Donald Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA
    • Tel.: +1-501-296-1503x1410; fax: +1-501-686-6442.
    • ,
  • Pei Lin

      Affiliations

    • Department of Pathology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA
    • Tel.: +1-501-686-7647; fax: +1-501-686-5874.
    • ,
  • James B Chen

      Affiliations

    • Division of Hematology/Oncology, Central Arkansas Healthcare System and University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA
    • Tel.: +1-501-257-1000x55925; fax: +1-501-257-4545.
    • ,
  • John D Shaughnessy

      Affiliations

    • Donna and Donald Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA
    • Tel.: +1-501-296-1503x1457; fax: +1-501-686-6442.

Received 23 May 2002 ,Accepted 21 December 2002.

References 

  1. Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer. 2001;92:1325–1330
  2. Golub T, Slonim D, Tamayo P, Huard C, Gaasenbeek M, Mesirov J, et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531–537
  3. Yeoh E, Ross M, Shurtleff S, Williams W, Patel D, Mahfouz R, et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133–143
  4. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al.  Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511
  5. Rosenwald A, Alizadeh A, Widhopf G, Simon R, Davis R, Yu X, et al.  Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med. 2001;194:1639–1647
  6. Klein U, Tu Y, Stolovitzky G, Mattioli M, Cattoretti G, Husson H, et al.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 2001;194:1625–1638
  7. Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E, et al.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99:1745–1757
  8. Hamblin T, Davis Z, Gardiner A, Oscier D, Stevenson F. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–1854
  9. Damle R, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S, et al.  IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840–1847
  10. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S, et al.  National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–4997
  11. Kyle R. Diagnostic criteria of multiple myeloma. Hematol. Oncol. Clin. North Am. 1992;6:347–358
  12. Zhan F, Tian E, Bumm K, Smith R, Barlogie B, Shaughnessy J. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late stage B cell development. Blood. 2003;101:1128–1140
  13. TreeView software program. Stanford: Stanford University; 1998.
  14. Eisen M, Spellman P, Brown P, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 1998;95:14863–14868
  15. Ikuta K, Takami M, Kim C, Honjo T, Miyoshi T, Tagaya Y, et al.  Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc. Natl. Acad. Sci. U.S.A. 1987;84:819–823
  16. Karagiannis S, Warrack J, Jennings K, Murdock P, Christie G, Moulder K, et al.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology. 2001;103:319–331
  17. Abts H, Jucker M, Diehl V, Tesch H. Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr. Leuk. Res. 1991;15:987–997
  18. Link D, Zutter M. The proto-oncogene c-fgr is expressed in normal mantle zone B lymphocytes and is developmentally regulated during myelomonocytic differentiation in vivo. Blood. 1995;85:472–479
  19. Waage A, Espevik T. TNF receptors in chronic lymphocytic leukemia. Leuk. Lymphoma. 1994;13:41–46
  20. Trentin L, Zambello R, Agostini C, Siviero F, Adami F, Marcolongo R, et al.  Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood. 1993;81:752–758
  21. Imani F, Rager K, Catipovic B, Marsh D. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J. Biol. Chem. 1997;272:7927–7931
  22. Kay N, Han L, Bone N, Williams G. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B cell apoptosis. Br. J. Haematol. 2001;112:760–767
  23. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J. Biol. Chem. 1998;273:7118–7122
  24. Hasegawa H, Nomura T, Kohno M, Tateishi N, Suzuki Y, Maeda N. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T cell leukemia cells. Blood. 2000;95:30–38
  25. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, et al.  Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 1997;272:13803–13809
  26. Davidson D, Veillette A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J. 2001;20:3414–3426
  27. Yang Q, Co D, Sommercorn J, Tonks N. Cloning and expression of PTP-PEST. A novel, human, nontransmembrane protein tyrosine phosphatase. J. Biol. Chem. 1993;268:6622–6628
  28. Hildebrand A, Romaris M, Rasmussen L, Heinegard D, Twardzik D, Border W, et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 1994;302:527–534
  29. Yamakawa K, Mitchell S, Hubert R, Chen X, Colbern S, Huo Y, et al.  Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum. Mol. Genet. 1995;4:709–716
  30. Lafreniere R, Kibar Z, Rochefort D, Han F, Fon E, Dube M, et al.  Genomic structure of the human GT334 (EHOC-1) gene mapping to 21q22.3. Gene. 1997;198:313–321
  31. Perou C, Leslie J, Green W, Li L, Ward D, Kaplan J. The Beige/Chediak–Higashi syndrome gene encodes a widely expressed cytosolic protein. J. Biol. Chem. 1997;272:29790–29794
  32. Abrink M, Aveskogh M, Hellman L. Isolation of cDNA clones for 42 different Kruppel-related zinc finger proteins expressed in the human monoblast cell line U-937. DNA Cell Biol. 1995;14:125–136
  33. Strissel P, Strick R, Tomek R, Roe B, Rowley J, Zeleznik-Le N, et al.  DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum. Mol. Genet. 2000;9:1671–1679
  34. Lydyard P, Grossi C. Development of the immune system. In: Roitt I, Brostoff J, Male D, editors. Immunology. 5th ed. London: Mosby; 1998. p. 156–70.
  35. Ibrahim S, Keating M, Do K, O’Brien S, Huh Y, Jilani I, et al.  CD38 expression as an important prognostic factor in B cell chronic lymphocytic leukemia. Blood. 2001;98:181–186
  36. Hamblin T, Orchard J, Ibbotson R, Davis Z, Thomas P, Stevenson F, et al.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99:1023–1029
  37. Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Dyer M, et al.  Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk. Res. 1998;22:185–191
  38. Treumann A, Lifely M, Schneider P, Ferguson M. Primary structure of CD52. J. Biol. Chem. 1995;270:6088–6099
  39. Rai K, Stephenson J. Campath-1H. Emerging frontline therapy in chronic lymphocytc leukemia. New York: The Parthenon Publishing Group; 2001.
  40. Keating M, Flinn I, Jain V, Binet J, Hillmen P, Byrd J, et al.  Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood. 2002;99:3554–3561
  41. Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R, et al.  An alternatively spliced form of CD79b gene may account for altered B cell receptor expression in B-chronic lymphocytic leukemia. Blood. 1999;93:2327–2335
  42. Thompson A, Talley J, Do H, Kagan H, Kunkel L, Berenson J, et al.  Aberrations of the B cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood. 1997;90:1387–1394
  43. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, et al.  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349–353
  44. Gotz R, Karch C, Digby M, Troppmair J, Rapp U, Sendtner M. The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum. Mol. Genet. 2000;9:2479–2489
  45. Kitada S, Andersen J, Akar S, Zapata J, Takayama S, Krajewski S, et al.  Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood. 1998;91:3379–3389
  46. Renner S, Weisz J, Krajewski S, Krajewska M, Reed J, Lichtenstein A. Expression of BAX in plasma cell dyscrasias. Clin. Cancer Res. 2000;6:2371–2380
  47. Randolph D, Huang G, Carruthers C, Bromley L, Chaplin D. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science. 1999;286:2159–2162
  48. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl. Acad. Sci. U.S.A. 1993;90:4631–4635

PII: S0145-2126(03)00015-8

doi: 10.1016/S0145-2126(03)00015-8

Leukemia Research
Volume 27, Issue 9 , Pages 765-774 , September 2003

Article Tools

* Image Usage & Resolution